MedTrace Logo

Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma

NCT06770699 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2025-01-13

No results posted yet for this study

Summary

This study aims to conduct a prospective cohort study to validate the prognostic performance of Tertiary Lymphoid Structures (TLSs) as a predictive marker in pathological tissue sections for nasopharyngeal carcinoma (NPC). The TLS assessment framework established in this research has the potential to serve as a reference for personalized treatment strategies in NPC patients.

Conditions

  • Nasopharyngeal Cancinoma (NPC)

Sponsors & Collaborators

  • Jiangxi Provincial Cancer Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2028-12-31
Completion
2029-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06770699 on ClinicalTrials.gov